J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.

(Bloomberg) -- Johnson & Johnson agreed to acquire Shockwave Medical Inc. for about $13.1 billion to bolster its expansion into making medical devices to treat heart disease. J&J will pay $335 a share ...

(Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical in a deal valued at $13.1 billion including debt, as it builds its cardiac-health-centric medical devices business to help drive ...

In a deal that might as well be termed a heart-to-heart, Shockwave Medical has made a bid to combine Neovasc’s cardiac device business with its own. Shockwave has offered up $27.25 in upfront cash for ...

Johnson & Johnson on Friday announced it would acquire heart device firm Shockwave Medical for $13.1 billion. It’s J&J’s second billion-dollar deal in the cardiovascular space in two years, following ...

Johnson & Johnson on Friday agreed to buy Shockwave Medical for $12.5 billion in a deal that would help broaden its portfolio of medical devices used in treating heart diseases. The acquisition gives ...

FREDERICK, MD, UNITED STATES, February 3, 2026 /EINPresswire.com/ — Limitless Evolution announces the launch of the ReGen Medical RCT Shockwave Device, an advanced ...